Member Info for potnak

TBH I don't think anything will come of c19\TYK2. We just don't have the resources to look at it. I do hope any data has been shared with the industry as a whole though.

Thanks Fadec. Look at that presentation and then look at our market cap. Either the presentation is wrong or we are a little undervalued. :-)

Think the TYK2\Covid thing will be soon or not at all.

Stoney - If it helps SAR to weather this storm, that's good enough for me. On a normal trading day, this would have given us loads to be happy about. Just read between the lines. We've got a 12-month cash runway. 12 months to get more deals and for SRRA to get sorted.

Thumbs up for Chris' post. Nail on the head. It's holding RNS. However we still to make another deal in the next nine months.

People are still dying of other diseases. The search for new drugs might be more focused but it will carry on.

Kind of agree, Utar but all R&D has ceased, everywhere. Those that have data are looking at their pipelines to see if they have anything that could help. It will probably come to nothing but I don't doubt for a minute that Tim and John haven't started looking at our data.

Realistically. We are on hold until all of this is over. There are bigger things to worry about. The only slight caveat to that is TYK2 as a treatment to C19. I've no doubt that at the very least. John and Tim will have explored the potential and will be sharing any data with the industry as a whole. Having said the above, Cancer and autoimmune isn't going to rest so maybe the big pharma's should either.

Being pragmatic. I can't see any reason to delay bad news. I just think it's later for no reason at all.

You've probably seen this but these are the figures that most governments are quoting. The key figures for me are active and serious cases. If China can turn the corner in the next two weeks, it will give confidence to the rest of the world and the markets may recover a bit. Don't look at the headlines. Active, serious and recovered is where it's at.

https://www.worldometers.info/coronavirus/

Fadec - they don't have anything else to tell us or as I believe, they can't tell us anything else because of an NDA. This is just a reminder of what we have.

Bod would also have to notify bad news.

The tweet is either clumsy\cynical way to try and placate the PI's or they are showing a bit of confidence, again, to try and calm us a little. We will get a deal for TYK2 this year, might not be great in the circumstances but We will get one. Will it come before fundraising? I don't know. I think the data we already have is being used to either close the deal or get some financial backing on board.

I think it's more likely, the data is good and they need a few hundred millions dollars to progress it. Milestones aren't their priority. Properly funding it is. Its unfortunate for SAR but thats the way it is.

They've delisted from AIM. Think they are on Nasdaq now. I saw the RNS but wasn't really following so didn't take any notice.

Still listed on here though.
https://www.lse.co.uk/ShareChat.asp?ShareTicker=SUMM&share=Summit-Therapeutics-Plc

A new patent would effectively reset the clock. More time to make a profit.

I'm not expecting to get any news until this lot of financials and the conf call is out of the way. If Gilead is going to make a move and finance SRA737. IMO, it'll be after they've settled their investors with some corporate waffle on the conf call. Not sure about the US but you wouldn't release price-sensitive news on a conf call. It has to be released to the market officially.

Don't think anyone is saying March are they? Well, not for a cashout. Just news of SRA737 funding will do me.

Probably Sierra PI's, just like us reading the Gilead news and getting 2 + 2 = 5. If Gilead (as we think they are going to) announce they will fund SRA737 it will give Sierra a boost. Who knows but it's getting exciting.

There is an image here https://www.fortyseveninc.com/science#CD47
Where it says amplifies the efficacy of CHK1 inhibitors.